B. Riley Securities initiated coverage on Electromed with a new price target
$ELMD
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
B. Riley Securities initiated coverage of Electromed with a rating of Buy and set a new price target of $38.00